Solid-phase hexapeptide ligand libraries open up new perspectives in the discovery of biomarkers in human plasma

Clinica Chimica Acta

Volumn 412, Issue 9-10, 2011, Pages 740-747

  Léger, Thibaut ^a   Lavigne, Damien ^b   Le Caër, Jean Pierre ^c   Guerrier, Luc ^d   Boschetti, Egisto ^d   Fareh, Jeannette ^b   Feldman, Laurent ^a,e   Laprévote, Olivier ^c,f   Meilhac, Olivier ^a  

^a INSERM   (France)

^b UMR 3145   (France)

^c CNRS   (France)

^d CEA SACLAY   (France)

^e BICHAT HOSPITAL   (France)

^f FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

2D electrophoresis; C reactive protein; Differential proteomics; Plasma pre treatment; SELDI TOF MALDI TOF mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; COMBINATORIAL LIBRARY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SOLID PHASE HEXAPEPTIDE LIGAND LIBRARY; TWO DIMENSIONAL ELECTROPHORESIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LIGANDS; MASS SPECTROMETRY; OLIGOPEPTIDES; PEPTIDE LIBRARY; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 79951720360     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.036     Document Type: Article

References (32)

1. Blanco-Colio L.M., Martin-Ventura J.L., Vivanco F., Michel J.B., Meilhac O., Egido J. Biology of atherosclerotic plaques: what we are learning from proteomic analysis. Cardiovasc Res 2006, 72:18-29.
2. Schaaij-Visser T.B., Graveland A.P., Gauci S., et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 2009, 15:7666-7675.
3. Rai A.J., Gelfand C.A., Haywood B.C., et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5:3262-3277.
4. Muthusamy B., Hanumanthu G., Suresh S., et al. Plasma Proteome Database as a resource for proteomics research. Proteomics 2005, 5:3531-3536.
5. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
6. Cellar N.A., Karnoup A.S., Albers D.R., Langhorst M.L., Young S.A. Immunodepletion of high abundance proteins coupled on-line with reversed-phase liquid chromatography: a two-dimensional LC sample enrichment and fractionation technique for mammalian proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:79-85.
7. Shores K.S., Knapp D.R. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis. J Proteome Res 2007, 6:3739-3751.
8. Vasudev N.S., Ferguson R.E., Cairns D.A., Stanley A.J., Selby P.J., Banks R.E. Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?. Proteomics 2008, 8:5074-5085.
9. Wang H., Clouthier S.G., Galchev V., et al. Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics 2005, 4:618-625.
10. Jmeian Y., El Rassi Z. Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids for in-depth proteomics analysis. Electrophoresis 2009, 30:249-261.
11. van den Broek I., Sparidans R.W., Schellens J.H., Beijnen J.H. Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum. Rapid Commun Mass Spectrom 2008, 22:2915-2928.
12. Guerrier L., Thulasiraman V., Castagna A., et al. Reducing protein concentration range of biological samples using solid-phase ligand libraries. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 833:33-40.
13. Boschetti E., Righetti P.G. The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species. J Proteomics 2008, 71:255-264.
14. Boschetti E., Righetti P.G. The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics 2009, 9:1492-1510.
15. Righetti P.G., Boschetti E., Zanella A., Fasoli E., Citterio A. Plucking, pillaging and plundering proteomes with combinatorial peptide ligand libraries. J Chromatogr A 2010, 1217:893-900.
16. Righetti P.G., Boschetti E., Kravchuk A.V., Fasoli E. The proteome buccaneers: how to unearth your treasure chest via combinatorial peptide ligand libraries. Expert Rev Proteomics 2010, 7:373-385.
17. Beseme O., Fertin M., Drobecq H., Amouyel P., Pinet F. Combinatorial peptide ligand library plasma treatment: advantages for accessing low-abundance proteins. Electrophoresis 2010, 31:2697-2704.
18. Roux-Dalvai F., Gonzalez de Peredo A., Simo C., et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 2008, 7:2254-2269.
19. Petri A.L., Simonsen A.H., Yip T.T., et al. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology. Acta Obstet Gynecol Scand 2009, 88:18-26.
20. Au J.S., Cho W.C., Yip T.T., et al. Deep proteome profiling of sera from never-smoked lung cancer patients. Biomed Pharmacother 2007, 61:570-577.
21. Sihlbom C., Kanmert I., Bahr H., Davidsson P. Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins. J Proteome Res 2008, 7:4191-4198.
22. Ernoult E., Bourreau A., Gamelin E., Guette C. A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. J Biomed Biotechnol 2010, 2010:927917.
23. Ridker P.M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007, 49:2129-2138.
24. Nelsestuen G.L., Zhang Y., Martinez M.B., et al. Plasma protein profiling: unique and stable features of individuals. Proteomics 2005, 5:4012-4024.
25. Dwivedi R.C., Krokhin O.V., Cortens J.P., Wilkins J.A. Assessment of the reproducibility of random hexapeptide peptide library-based protein normalization. J Proteome Res 2010, 9:1144-1149.
26. Farinazzo A., Restuccia U., Bachi A., et al. Chicken egg yolk cytoplasmic proteome, mined via combinatorial peptide ligand libraries. J Chromatogr A 2009, 1216:1241-1252.
27. Castagna A., Cecconi D., Sennels L., et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res 2005, 4:1917-1930.
28. Mouton-Barbosa E., Roux-Dalvai F., Bouyssie D., et al. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics 2010, 9:1006-1021.
29. Fasoli E., Farinazzo A., Sun C.J., et al. Interaction among proteins and peptide libraries in proteome analysis: pH involvement for a larger capture of species. J Proteomics 2010, 73:733-742.
30. Coligan J.E. Commonly used detergents. Curr Protoc Immunol 2001, Appendix 1:Appendix 1D.
31. Hortin G.L. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006, 52:1223-1237.
32. Hartwig S., Czibere A., Kotzka J., et al. Combinatorial hexapeptide ligand libraries (ProteoMiner): an innovative fractionation tool for differential quantitative clinical proteomics. Arch Physiol Biochem 2009, 115:155-160.